Biotech · Private company
Aurinia Pharmaceuticals Inc.
Track this companyFree. Adds Aurinia Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials122 recruiting or active
Pipeline programs18From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline18
- 0.05% Voclosporin Ophthalmic Solution (VOS)Phase 3 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- 0.10% VOSPhase 3 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- 0.20% VOSPhase 3 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle Ophthalmic SolutionPhase 3 · Dry Eye SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- VoclosporinPhase 3 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- VoclosporinPhase 3 · Adolescent Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- AritinerceptPhase 2 · Myasthenia Gravis, GeneralizedClinicalTrials.gov · fetched Nov 12, 2026
- Restasis®Phase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- VoclosporinPhase 2 · Focal Segmental GlomerulosclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Voclosporin High DosePhase 2 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- Voclosporin Low DosePhase 2 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- Voclosporin Ophthalmic SolutionPhase 2 · Dry EyeClinicalTrials.gov · fetched Nov 12, 2026
- SimvastatinPhase 1 · Drug-drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- VoclosporinPhase 1 · Drug-drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- belimumab, obinutuzumab or anifrolumabLupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- corticosteroidLupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- LUPKYNISLupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- mycophenolic acid analog (MPAA)Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Study of Aritinercept in Patients With Generalized Myasthenia GravisPHASE1_PHASE2 · RECRUITING · started Apr 22, 2026ClinicalTrials.gov NCT07596901 · fetched Nov 12, 2026
- PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus NephritisPHASE4 · RECRUITING · started Apr 22, 2026ClinicalTrials.gov NCT07611214 · fetched Nov 12, 2026
- Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus NephritisPHASE3 · TERMINATED · started Mar 28, 2024ClinicalTrials.gov NCT05962788 · fetched Nov 12, 2026
- Voclosporin in Adolescent and Pediatric Subjects With Lupus NephritisPHASE3 · TERMINATED · started Oct 10, 2023ClinicalTrials.gov NCT05288855 · fetched Nov 12, 2026
- A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the USCOMPLETED · started Apr 5, 2022ClinicalTrials.gov NCT05337124 · fetched Nov 12, 2026
- Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of SimvastatinPHASE1 · COMPLETED · started Jan 24, 2022ClinicalTrials.gov NCT05306379 · fetched Nov 12, 2026
- Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye SyndromePHASE2_PHASE3 · COMPLETED · started Oct 14, 2019ClinicalTrials.gov NCT04147650 · fetched Nov 12, 2026
- Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With VoclosporinPHASE3 · COMPLETED · started Sep 29, 2019ClinicalTrials.gov NCT03597464 · fetched Nov 12, 2026
- Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye DiseasePHASE2 · COMPLETED · started Aug 13, 2018ClinicalTrials.gov NCT03597139 · fetched Nov 12, 2026
- Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental GlomerulosclerosisPHASE2 · TERMINATED · started Jun 21, 2018ClinicalTrials.gov NCT03598036 · fetched Nov 12, 2026
- Aurinia Renal Response in Active Lupus With VoclosporinPHASE3 · COMPLETED · started May 17, 2017ClinicalTrials.gov NCT03021499 · fetched Nov 12, 2026
- AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)PHASE2 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02141672 · fetched Nov 12, 2026